The trademark REPEL-IN7 was filed by GERMED FARMACĂUTICA, LDA, a corporation established under the laws of the Portuguese Republic (the "Applicant"). The application was published for oppositions on August 9, 2016, and received one opposition filed on November 7, 2016 by Novartis AG on Likelihood of confusion. the opponent was represented by FRIEDRICH GRAF VON WESTPHALEN & PARTNER MBB and proceedings were handled in English, and the oppositon was dismissed by the Euorpean Union Intellectual Property Office with decision issued November 7, 2016
The application was filed in Portuguese, and Portuguese was also language of all opposition proceedings (English was selected as the second language).